Your browser doesn't support javascript.
loading
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience.
Innocenti, Idanna; Morelli, Francesca; Autore, Francesco; Piciocchi, Alfonso; Frustaci, Annamaria; Mauro, Francesca R; Schiattone, Luana; Trentin, Livio; Del Poeta, Giovanni; Reda, Gianluigi; Rigolin, Gian M; Ibatici, Adalberto; Ciolli, Stefania; Coscia, Marta; Sportoletti, Paolo; Murru, Roberta; Levato, Luciano; Gentile, Massimo; D'Arena, Giovanni; Efremov, Dimitar G; Tedeschi, Alessandra; Scarfò, Lydia; Cuneo, Antonio; Foà, Robin; Laurenti, Luca.
Afiliación
  • Innocenti I; Institute of Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Morelli F; Institute of Haematology, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Autore F; Institute of Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Piciocchi A; Italian Group for Adult Haematological Diseases (GIMEMA), Data Centre, Roma, Italy.
  • Frustaci A; Haematology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Mauro FR; Haematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy.
  • Schiattone L; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy.
  • Trentin L; Haematology and Clinical Immunology, Department of Medicine, Padova, Italy.
  • Del Poeta G; Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Roma, Italy.
  • Reda G; IRCCS Ca' Granda - Università degli Studi, Milano, Italy.
  • Rigolin GM; Haematology section - University of Ferrara, Ferrara, Italy.
  • Ibatici A; Division of Haematology and Bone Marrow Transplant, IRCCS San Martino-IST, Genova, Italy.
  • Ciolli S; Haematology Unit, Careggi Hospital, Firenze, Italy.
  • Coscia M; Division of Haematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Sportoletti P; Haematology and Clinical Immunology, University of Perugia, Perugia, Italy.
  • Murru R; Haematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, AO Brotzu, Cagliari, Italy.
  • Levato L; Haematology Unit, A. Pugliese Hospital, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy.
  • Gentile M; Haematology Section, Cosenza Hospital, Cosenza, Italy.
  • D'Arena G; Haematology and Stem cell Transplantation Unit, IRCCSCROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
  • Efremov DG; Molecular Haematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Tedeschi A; Haematology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Scarfò L; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy.
  • Cuneo A; Haematology section - University of Ferrara, Ferrara, Italy.
  • Foà R; Haematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy.
  • Laurenti L; Institute of Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Br J Haematol ; 187(1): e8-e11, 2019 10.
Article en En | MEDLINE | ID: mdl-31364153
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia